CEVEC Pharmaceuticals GmbH
CEVEC is a biotechnology company specialized in cell line and process development for the scalable production of high-end biologics, including gene therapy vectors and complex glycosylated recombinant proteins, from R&D to production scale.
With CAP-Go, CEVEC enables theefficient production of complex recombinant proteins, like FVIII, C1-Inhibitor, laminins, A1AT and others, with high titers and excellent pharmacokinetics mediated by tailor-made glycosylation.
With CAP-GT, CEVEC has developed a scalable platform for gene therapy vector manufacturing based on suspension cell lines. For AAV (Adeno-Associated Viral) vectors CEVEC offers a unique fully scalable, stable helper virus-free production system.
CEVEC Pharmaceuticals at a glance:
| Field of Activity |
Development, services and licensing of human cell-based production platforms for biopharmaceuticals. |
| Ownership Structure and Financing | Privately owned. Investors include Peppermint Venture Partners, Creathor Venture, NRW.Bank, KfW Bank, G.A.T. Holding, and others. |
| Partners | Selected license partners: Beckmann Research Institute/City of Hope, Biotest, CSL Limited, medac, Provecs Medical, BioLamina, CellGenix; CDMO partners: Paragon Bioservices Inc., GenIbet Biopharmaceuticals |
| Technology and Unique Selling Point | CEVEC’s CAP®-platforms for complex proteins and viral vectors used as therapeutics and in gene therapy applications are based on its proprietary CAP®-Technology, a unique expression system using human suspension cells. • Fully scalable and cost-efficient • GMP compatible process development from R&D to production scale • Authentic tailor-made glycosylation (CAP-Go) • Outstanding pharmacokinetic profi les and high yields of recombinant proteins • Helper virus-free producer cell line for AAV vectors |
| Products / Services | Cell line and process development and technology licensing for the manufacturing of tailor-made recombinant glycoproteins and gene therapy vectors from R&D to production scale. |
| Membership in networks / associations | Bio Deutschland, Alliance for Regenerative Medicine (ARM), Dechema, BioRiver, Bio Cologne |
| Date of Incorporation | 2003 |
Contact:
| Address | Gottfried-Hagen-Straße 60-62 51105 Cologne |
| Telephone/Telefax | +49 221 460 208-00/-01 |
| info@cevec.com | |
| Web-Address | www.cevec.com |
| Social Media |
Business segment:
The expert in scalable, cost-effi cient
production of complex glycosylated
proteins and viral vectors.